ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135929 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135929; 2) Community: the network communities that were significantly associated with the response to NSC 135929; 3) Molecule: the relationships between components within communities and NSC 135929; 4) MDR: the compounds that were significantly associated with the NSC 135929.

NSC Compound Enrichment Correlation
NSC 711582 Null 0.000108967261726037 0.55067102
NSC 639503 Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride 0.000150163566228977 0.57418509
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.000176661849797006 0.42168853
NSC 150555 Afungin 0.000316293616993019 0.60133461
NSC 676536 2,5-bis(3-Amino-2,4,6-trinitrophenyl)-1,3,4-thiadiazole 0.000316293616993019 0.59220207
NSC 677256 Null 0.000316293616993019 0.547546
NSC 339137 PHYSALOLACTONE 0.000455867606843419 0.38904265
NSC 624657 ANTINEOPLASTIC-624657 0.000455867606843419 0.48937953
NSC 665514 Null 0.000455867606843419 0.40533715
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.000455867606843419 0.46249809
Total:92  Current:1    [First] [Prev] [Next] [Last]